September 12, 2023 Comments Off on Drug Patent Expirations for the Week of September 10, 2023 Posted in: Uncategorized
TYZEKA (telbivudine) Novartis Patent: 7,589,079 Expiration: Sep 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
September 12, 2023 Comments Off on New patent for Abbvie drug UBRELVY Posted in: Patent Added Annual Drug Patent Expirations for UBRELVY Ubrelvy is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Abbvie drug UBRELVY appeared first on DrugPatentWa…
